Carlos
Garzón Montesinos
Forscher in der Zeit 2016-2017
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (1)
2019
-
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome
Neurobiology of Disease, Vol. 125, pp. 92-106